Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartz

Showing results (1001-1010 of 1,151) with videos related to

Pageof 116
Sort By:
Royal Society Open Science|May 21, 2020
Organic residue analysis shows sub-regional patterns in the use of pottery by Northern European hunter-gatherersBlandine Courel, Harry K Robson, Alexandre Lucquin, et al.
Journal of Fish Biology|July 13, 2016
Fish composition and species richness in eastern South American coastal lagoons: additional support for the freshwater ecoregions of the worldA C Petry, T F R Guimarães, F M Vasconcellos, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic PainRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
Royal Society Open Science|September 3, 2020
Correction to 'Organic residue analysis shows sub-regional patterns in the use of pottery by Northern European hunter-gatherers'Blandine Courel, Harry K Robson, Alexandre Lucquin, et al.
Journal of Medicinal Chemistry|June 26, 2009
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonistsRichard A Hartz, Vijay T Ahuja, Maria Rafalski, et al.
Journal of Medicinal Chemistry|December 4, 2009
A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a potent, orally bioavailable corticotropin-releasing factor-1 receptor antagonistRichard A Hartz, Vijay T Ahuja, Xiaoliang Zhuo, et al.
Psychological Medicine|July 7, 2021
Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorderEmma C Johnson, Manav Kapoor, Alexander S Hatoum, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88Carolyn D Dzierba, Yingzhi Bi, Bireshwar Dasgupta, et al.
Addiction (Abingdon, England)|April 25, 2012
CHRNB3 is more strongly associated with Fagerström test for cigarette dependence-based nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies resultsJohn P Rice, Sarah M Hartz, Arpana Agrawal, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agentsJeffrey A Deskus, Douglas D Dischino, Ronald J Mattson, et al.
Pageof 116

Showing results (1001-1010 of 1,151) with videos related to

Sort By:
Pageof 116
Royal Society Open Science|May 21, 2020
Organic residue analysis shows sub-regional patterns in the use of pottery by Northern European hunter-gatherersBlandine Courel, Harry K Robson, Alexandre Lucquin, et al.
Journal of Fish Biology|July 13, 2016
Fish composition and species richness in eastern South American coastal lagoons: additional support for the freshwater ecoregions of the worldA C Petry, T F R Guimarães, F M Vasconcellos, et al.
Journal of Medicinal Chemistry|July 16, 2021
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic PainRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.
Royal Society Open Science|September 3, 2020
Correction to 'Organic residue analysis shows sub-regional patterns in the use of pottery by Northern European hunter-gatherers'Blandine Courel, Harry K Robson, Alexandre Lucquin, et al.
Journal of Medicinal Chemistry|June 26, 2009
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonistsRichard A Hartz, Vijay T Ahuja, Maria Rafalski, et al.
Journal of Medicinal Chemistry|December 4, 2009
A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a potent, orally bioavailable corticotropin-releasing factor-1 receptor antagonistRichard A Hartz, Vijay T Ahuja, Xiaoliang Zhuo, et al.
Psychological Medicine|July 7, 2021
Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorderEmma C Johnson, Manav Kapoor, Alexander S Hatoum, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88Carolyn D Dzierba, Yingzhi Bi, Bireshwar Dasgupta, et al.
Addiction (Abingdon, England)|April 25, 2012
CHRNB3 is more strongly associated with Fagerström test for cigarette dependence-based nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies resultsJohn P Rice, Sarah M Hartz, Arpana Agrawal, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agentsJeffrey A Deskus, Douglas D Dischino, Ronald J Mattson, et al.
Pageof 116